Shares of Hims & Hers Health, Inc. (HIMS) surged nearly 16% in Tuesday’s regular session and extended gains in after hours ...

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term losses from the stock of late, since ...

The company reported adjusted earnings per share of $0.28 on revenue of $586 million – a significant rise compared to last ...

Hims & Hers stock has risen by 20% after announcing a partnership to sell the popular weight-loss drug Wegovy.

CEO Andrew Dudum said the funds will allow the company to grow internationally and invest in artificial intelligence.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Hims & Hers Health (NYSE:HIMS) reported first-quarter earnings on Monday after the market closed and rocketed 18% after ...

Hims & Hers delivered impressive Q1 2025 results, with 111% y/y revenue growth and 38% y/y subscriber growth. Check out why I ...

Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next chief ...

Hims research determined which fast food burgers have the healthiest nutritional content and which ones to save for a special ...

Hims & Hers Health first-quarter revenue more than doubled as subscribers rose 38%, while its second-quarter sales outlook ...

Hims & Hers shares fell in extended trading on Monday after the company reported first-quarter earnings that offered soft ...